Estimating cardiovascular risk in Spain using different algorithms

被引:0
|
作者
Comin, Eva
Solanas, Pascual
Cabezas, Carmen
Subirana, Isaac
Ramos, Rafel
Gene-Badia, Joan
Cordon, Ferran
Grau, Maria
Cabre-Vila, Joan J.
Marrugat, Jaume
机构
[1] Inst Municipal Invest Med, Unitat Lipids & Epidemiol Cardiovasc, E-08003 Barcelona, Spain
[2] Inst Catala Salut, Barcelona, Spain
[3] Inst Catala Salut, Unitat Docent Med Familia Girona, Barcelona, Spain
[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[5] Inst Catala Salut, Fdn Gol Gurina, Barcelona, Spain
[6] Univ Barcelona, Consorci Atencio Primaria Eixample, Barcelona, Spain
[7] EAP Reus 1, CAP Sant Pere, Barcelona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2007年 / 60卷 / 07期
关键词
coronary disease; risk factors; hypercholesterolemia; cardiovascular risk;
D O I
10.1016/S1885-5857(08)60004-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives. Although its incidence is low, cardiovascular disease is the most common cause of morbidity and mortality in Spain. A number of different algorithms can be used to calculate cardiovascular disease risk for primary prevention, but their ability to identify patients who will experience a cardiovascular event is not well understood. The objective of this study was to compare the results of using the original Framingham algorithm and two adaptations for low-risk countries: the REGICOR (Registre Gironi del cor) and SCORE (Systematic COronary Risk Evaluation) algorithms. Methods. All cardiovascular events during 5-year follow-up in a cohort of patients without coronary disease in nine autonomous Spanish regions were recorded. The levels of different cardiovascular risk factors were measured between 1995 and 1998. Participants were considered high-risk if their 10-year risk was >= 20% with the Framingham algorithm, >= 10 %, >= 15 % or >= 20 % with REGICOR, and >= 5 % with SCORE. Results. In total, 180 (3.1 %) coronary events (112 in men and 68 in women) occurred among the 5732 (57.3 % female) participants during follow-up. Of these, 43 died from cerebrovascular disease, and 24 had a non-coronary vascular event. The REGICOR algorithm had the highest positive predictive value for coronary and cardiovascular disease in all age groups. Moreover, with a 10-year risk limit of 10%, it classified less of the population aged 35-74 years as high-risk (i.e., 12.4 %) than the Framingham algorithm (i.e., 22.4 %). The SCORE and Framingham algorithms classified 8.4 % and 16.6 % of the population aged 35-64 years, respectively, as having a high cardiovascular disease risk; with REGICOR, the figure was 7.5 %. Conclusions. The REGICOR adapted algorithm was the best predictor of cardiovascular events and classified a smaller proportion of the Spanish population aged 35-74 years as high risk than alternative algorithms.
引用
收藏
页码:693 / 702
页数:10
相关论文
共 50 条
  • [41] Estimating Cardiovascular Risk in HIV-Infected Patients
    Bittencourt, Marcio Sommer
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (01) : 76 - 77
  • [42] On the importance of estimating renal function for cardiovascular risk assessment
    Segura, J
    Ruilope, LM
    Zanchetti, A
    JOURNAL OF HYPERTENSION, 2004, 22 (09) : 1635 - 1639
  • [43] Prevalence of Cardiovascular Risk Factors in Spain: A Systematic Review
    Sacramento-Pacheco, Jennifer
    Sanchez-Gomez, Maria Begona
    Gomez-Salgado, Juan
    Novo-Munoz, Maria Mercedes
    Duarte-Climents, Gonzalo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [44] Calibrating the SCORE cardiovascular risk chart for use in Spain
    Sans, Susana
    Fitzgerald, Anthony P.
    Royo, David
    Conroy, Ronan
    Graham, Ian
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (05): : 476 - 485
  • [45] Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting list
    Herzog, Anna Laura
    Kalogirou, Charis
    Wanner, Christoph
    Lopau, Kai
    CLINICAL KIDNEY JOURNAL, 2020, 13 (02) : 150 - 158
  • [46] Detection Study of Cardiovascular Risk in Toledo pharmacies (Spain)
    Riolobos, Estrada G.
    Barrera, Peludo N.
    Alonso, Rodriguez A.
    Zorrilla, Martinez M. J.
    Dago, A.
    PHARMACEUTICAL CARE ESPANA, 2020, 22 (02): : 54 - 74
  • [47] Cardiovascular Risk Profiles by Occupation in Madrid Region, Spain
    Zimmermann Verdejo, Marta
    Gonzalez Gomez, Maria Fernanda
    Galan Labaca, Inaki
    REVISTA ESPANOLA DE SALUD PUBLICA, 2010, 84 (03): : 305 - 320
  • [48] Estimating risk of cardiovascular pharmaceuticals in freshwaters using zebrafish embryotoxicity test - statins threat revealed
    Matijevic, Gabrijela
    Babic, Sanja
    Marsavelski, Aleksandra
    Stipanicev, Drazenka
    Repec, Sinisa
    Coz-Rakovac, Rozelindra
    Klobucar, Goran
    CHEMOSPHERE, 2023, 313
  • [49] Cardiovascular risk assessment using different equations:: Comparison of high risk prevalence in dyslipemic patients
    Fornasini, M
    Brotons, C
    Casanovas, J
    Iruela, A
    Vinyeta, R
    Martínez, M
    Bartés, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 118 - 118
  • [50] ASSESSMENT OF RISK FACTORS FOR ATHEROSCLEROSIS IN INDIVIDUALS OF DIFFERENT CATEGORIES OF CARDIOVASCULAR RISK USING THE ATEROSTOP CALCULATOR
    Zubareva, M. Y.
    Malyshev, P. P.
    Ansheles, A. A.
    Sergienko, I., V
    KARDIOLOGIYA, 2021, 61 (03) : 12 - 17